Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $199.4 million versus the consensus estimate of $203.56 million.

“For the second quarter this year, we again exceeded guidance for Gross Profit and Adjusted EBITDA Margins driven by strong pricing and leverage from revenue growth,” said William J. Grubbs, President and Chief Executive Officer. “The market remains robust and supports our initiatives aimed at accelerating revenue growth as we progress throughout the year.”

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.